MyFinsight
Home
Blog
About
Contact
Download
Download image
Net gain
-$1,793,381
Change in fair value of
warrant liabilities
-$16,000
Gain from operations
-$1,304,698
Fair value option
loss on convertible...
-$344,000
Interest expense
-$132,512
Change in fair value of
equity payable
$28,171
Total operating
expenses
$1,304,698
General and
administrative
$1,247,077
Research and development
$57,621
Back
Back
Income Statement
source: myfinsight.com
ZyVersa Therapeutics, Inc. (ZVSA)
ZyVersa Therapeutics, Inc. (ZVSA)